Flora Growth Corp. Announces an Exclusive Worldwide Partnership with Legendary Superstar Hulk Hogan
Ryan Allway
August 1st, 2023
News, Top News, Top Story
Fort Lauderdale, Florida–(Newsfile Corp. – August 1, 2023) – Flora Growth Corp. (NASDAQ: FLGC) (“Flora” or the “Company”), a consumer-packaged goods leader serving all 50 states and 13 countries with 15,000+ points of distribution around the world and a pharmaceutical distributor in 28 countries, is proud to announce that it has entered an exclusive worldwide partnership with WWE legend Hulk Hogan.
Flora will launch legendary superstar Hulk Hogan’s comprehensive consumer products portfolio through Just Brands. Under the agreement, Flora will produce and sell Hulk Hogan products globally, including Hulk Hogan’s hemp-derived pre-rolls, topicals, flower, edibles, CBD, HHC, Delta 8, and Kratom.
“Flora is thrilled to be selected as the exclusive producer for Hulk Hogan products,” said Clifford Starke, Chief Executive Officer of Flora. “Our award-winning products and Hulk Hogan’s status as an icon and American hero will make us the ultimate championship tag team.”
“Our exclusive partnership with Flora allows us to deliver Hulk Hogan’s vision of a premier brand to the consumer,” noted Hulk Hogan, the face of iconic trademarks including “Hulk Hogan,” “Hulkamania,” “Hollywood Hulk Hogan,” and the “Hulkster.”
“I am excited to stand behind my brand with Flora. I used to tell my Hulkamaniacs to say their prayers, take their vitamins, and they will never go wrong. Well, let me tell you something, brother. Flora is the ideal partner to make my CBD-infused vitamins,” stated Hulk Hogan.
Chad Bronstein, Chairman and President of Carma HoldCo, the leader in licensing for legends and the holding company of iconic brands such as Mike Tyson’s “Tyson 2.0,” Ric Flair’s “Ric Flair Drip,” “Immortal by Hulk Hogan,” and others, said this about the partnership:
“We are excited to join forces with Flora to bring Hulk Hogan’s iconic brand to new global audiences. When you take Flora’s vast distribution network, our ability to create one-of-a-kind consumer experiences, with Hulk Hogan’s status and legacy, all roads lead to legendary.”
The exclusive agreement has an initial term of three years with mutually agreed-upon consecutive one-year renewal periods. The anticipated initial 24-month top-line sales pilot target is $20 million. Flora is expected to pay a royalty and a license fee for the sales of Hulk Hogan-branded products.
**Use Promo Code HULK to Earn 10% Off Your Next Purchase**
About Hulk Hogan
Hulk Hogan is a pop-culture icon widely regarded as the greatest professional wrestler of all time. The American Hero entertained and inspired tens of millions worldwide for over 35 years, transcending the ring and ushering in the new era of global sports entertainment as we know it today. The Hulk Hogan phenomenon was the first of its kind-and remains an ever-present influence today, generations later.
Hulk Hogan headlined eight editions of WWE’s signature event Wrestlemania and reigned as champion for a record-setting 1,474 days, one of the longest in the promotion’s history. His match with Andre the Giant still holds the American television viewership records for wrestling with 33 million viewers. His crossover appeal led to notable acting roles spanning film and television, including appearances in Rocky III, No Holds Barred, Suburban Commando, and the acclaimed Hogan Knows Best.
About Carma HoldCo Inc.
Carma HoldCo Inc. (Carma) creates iconic global brands through licensing and is the brand house behind Mike Tyson’s “TYSON 2.0,” Ric Flair’s “Rich Flair Drip,” two-time GRAMMY winner Future’s “EVOL by Future,” and “Immortal by Hulk Hogan.” Carma product distribution spans over 100,000 retailers across 40 states, select Canadian provides, and 17 countries worldwide. For more information on Carma HoldCo, visit www.carmahold.com
About Flora Growth Corp.
Flora Growth Corp. is a consumer-packaged goods leader serving all 50 states with 15,000+ points of distribution around the world and a pharmaceutical distributor in 28 countries. In the United States, Flora’s lifestyle business has established a robust presence across all 50 states, providing us with a solid foundation. Furthermore, we believe we possess substantial potential for international expansion. Based in Germany, we have successfully developed a strong distribution network delivering lifestyle and wellness products to 28 countries. For more information, kindly visit www.floragrowth.com or follow @floragrowthcorp on social media.
Cannot view this image? Visit:
https://images.newsfilecorp.com/files/9845/175654_1.jpeg
https://www.phatebo.de/home-en
Investor Relations:
Investor Relations ir@floragrowth.com
Clifford Starke Clifford.Starke@floragrowth.com
Media:
Cautionary Statement Concerning Forward-Looking Statements
This press release contains “forward-looking statements,” as defined by federal securities laws. Forward-looking statements reflect Flora’s current expectations and projections about future events at the time, and thus involve uncertainty and risk. The words “believe,” “expect,” “anticipate,” “will,” “could,” “would,” “should,” “may,” “plan,” “estimate,” “intend,” “predict,” “potential,” “continue,” and the negatives of these words and other similar expressions generally identify forward-looking statements. Such forward-looking statements are subject to various and risks and uncertainties, including those described under section entitled “Risk Factors” in Flora’s Annual Report on Form 10K filed with the SEC on March 31, 2023, as such factors may be updated from time to time in Flora’s periodic filings with the SEC, which are accessible on the SEC’s website at www.sec.gov. Accordingly, there are or will be important factors that could cause actual outcomes or results to differ materially from those indicated in these statements. These factors should not be construed as exhaustive and should be read in conjunction with the other cautionary statements that are included in this release and in Flora’s filings with the SEC. While forward-looking statements reflect Flora’s good faith beliefs, they are not guarantees of future performance. Flora disclaims any obligation to publicly update or revise any forward-looking statement to reflect changes in underlying assumptions or factors, new information, data or methods, future events or other changes after the date of this press release, except as required by applicable law. You should not place undue reliance on any forward-looking statements, which are based on information currently available to Flora (or to third parties making the forward-looking statements).
This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.
About Ryan Allway
Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.
Search CannabisFN
Press Coverage
Psychedelics Index
Top Videos
Alan Brochstein’s 420 Investor is the go-to community for investors to learn, explore, and profit from the marijuana companies. The main goal of 420 Investor is to provide real-time, objective information about the top marijuana companies in the market in order to help investors capitalize on cannabis.
Rob is the co-founding President of Pelorus Equity Group and has more than 18 years of experience in the real estate finance industry. Since the formation of Pelorus in 2010, he has raised more than $175,000,000 in secured real estate transactions. Rob’s primary role at Pelorus Equity Group is the development of strategic alliances with […]
Delta 9’s wholly-owned subsidiary, Delta 9 Bio-Tech Inc., is a licensed producer of medical marijuana pursuant to the ACMPR and operates an 80,000 square foot production facility in Winnipeg, Manitoba, Canada . Delta 9’s shares trade on the TSX Venture Exchange under the symbol “NINE”.
cbdMD Inc. (NYSE: YCBD) is a nationally recognized consumer cannabidiol (CBD) brand whose current products include CBD tinctures, CBD gummies, CBD topicals, CBD bath bombs, CBD vape oils, and CBD pet products.
Network Partners
About CFN Media Group
CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.
Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.
Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer
